Sector Chart Interpace Biosciences, Inc.

Stocks

IDXG

US46062X4025

Healthcare Facilities & Services

Market Closed - OTC Markets 17:49:26 16/10/2026 +03			5-day change	1st Jan Change
5.150 ^USD	-2.28%		-14.17%	-16.27%

10-15	Interpace Biosciences, Inc. Provides Preliminary, Unaudited Earnings Guidance for the Third Quarter Ended September 30, 2026	CI
08-10	Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Medical & Diagnostic Laboratories

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
INTERPACE BIOSCIENCES, INC.	28.54M	-	-	-	-	-
CVS HEALTH CORPORATION	118B
HCA HEALTHCARE, INC.	99.34B
NATERA, INC.	56.71B					-
QUEST DIAGNOSTICS INCORPORATED	25.94B
LABCORP HOLDINGS INC.	25.79B